Blog
Curve Therapeutics Secures £405m in Funding to Revolutionize Cancer Treatment
📢 Curve Therapeutics secures £40.5m in funding led by Pfizer Ventures to advance cancer target screening and peptide pipeline! 💪🔬
Revolutionary Genetic Editing Breakthroughs and Biogen’s Disappointing Q4 Results
📰 Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe 🚀 🔍 Dive into the latest advancements in genetic editing and pharmaceuticals, covering prime editing, PRINT technology, Biogen's Q4 results, and more. 🧬🔬 3. Create a catchy headline for the wordpress article. 4. Create a Meta Description for the wordpress article. 3. Catchy headline: Revolutionizing Genetics: Prime Editing, Universal CAR T, Biogen's Q4 Disappointment & More 4. Meta Description: Explore the cutting-edge world of genetic editing with prime editing, universal CAR T, and Biogen's Q4 results. Stay informed!
The High Costs of Low-Quality Albumin: Risks and Solutions
1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍
Genezen Revolutionizes Vector Production with CSL Licensing
📢 Genezen becomes first CDMO to license CSL's Cytegrity system, helping to alleviate viral vector shortage and improve quality. 🚀👩🔬💊
Revolutionary Breakthrough: Accessible NK Cell Therapies
🔬 Learn how Artiva Biotherapeutics is revolutionizing cell therapies with NK cells for easier access and improved outcomes.
Boosting Biopharmaceutical Manufacturing with Real-Time Control
📰 Optimizing Critical Quality Attributes during Processing explores how a cyber-physical system and digital twin can improve biopharmaceutical manufacturing. 💊🔬🚀
Price and Time Barriers for Amtagvi Rollout
📢 Iovance struggles with price and time constraints hindering the Amtagvi rollout. Read more on our home page! 🏠
Biopharma Struggles with Single-Use Standardization
📰 Lack of Single-Use Standardization a Challenge for Biopharma: Industry struggles with flexibility, automation, and supplier dependency. 💊💼🔬
CDMO Incog Supercharges Operations with $75M Expansion
🔧 CDMO Incog gears up with 💰$75m expansion to boost filling capacity. Exciting times ahead! 🚀🔬👩🔬 pharmaceuticals growth
Firefly Raises $94 Million to Revolutionize Cancer Treatment
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
